A citation-based method for searching scientific literature

Gabriele Zoppoli, Marie Regairaz, Elisabetta Leo, William C Reinhold, Sudhir Varma, Alberto Ballestrero, James H Doroshow, Yves Pommier. Proc Natl Acad Sci U S A 2012
Times Cited: 152







List of co-cited articles
775 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
50

SLFN11 Blocks Stressed Replication Forks Independently of ATR.
Junko Murai, Sai-Wen Tang, Elisabetta Leo, Simone A Baechler, Christophe E Redon, Hongliang Zhang, Muthana Al Abo, Vinodh N Rajapakse, Eijiro Nakamura, Lisa M Miller Jenkins,[...]. Mol Cell 2018
100
50

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition.
Junko Murai, Ying Feng, Guoying K Yu, Yuanbin Ru, Sai-Wen Tang, Yuqiao Shen, Yves Pommier. Oncotarget 2016
131
41

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs.
Vanesa Nogales, William C Reinhold, Sudhir Varma, Anna Martinez-Cardus, Catia Moutinho, Sebastian Moran, Holger Heyn, Ana Sebio, Agusti Barnadas, Yves Pommier,[...]. Oncotarget 2016
85
47

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
Eric E Gardner, Benjamin H Lok, Valentina E Schneeberger, Patrice Desmeules, Linde A Miles, Paige K Arnold, Andy Ni, Inna Khodos, Elisa de Stanchina, Thuyen Nguyen,[...]. Cancer Cell 2017
198
38

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
Benjamin H Lok, Eric E Gardner, Valentina E Schneeberger, Andy Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A Teicher, Nadeem Riaz, Simon N Powell,[...]. Clin Cancer Res 2017
143
37

SLFN11 inhibits checkpoint maintenance and homologous recombination repair.
Yanhua Mu, Jiangman Lou, Mrinal Srivastava, Bin Zhao, Xin-hua Feng, Ting Liu, Junjie Chen, Jun Huang. EMBO Rep 2016
72
45

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
M Catherine Pietanza, Saiama N Waqar, Lee M Krug, Afshin Dowlati, Christine L Hann, Alberto Chiappori, Taofeek K Owonikoko, Kaitlin M Woo, Robert J Cardnell, Junya Fujimoto,[...]. J Clin Oncol 2018
151
29

Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors.
Sai-Wen Tang, Anish Thomas, Junko Murai, Jane B Trepel, Susan E Bates, Vinodh N Rajapakse, Yves Pommier. Clin Cancer Res 2018
37
70

Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.
Junko Murai, Anish Thomas, Markku Miettinen, Yves Pommier. Pharmacol Ther 2019
49
53

DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs.
Manqing Li, Elaine Kao, Dane Malone, Xia Gao, Jean Y J Wang, Michael David. Nat Struct Mol Biol 2018
39
64

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11.
Manqing Li, Elaine Kao, Xia Gao, Hilary Sandig, Kirsten Limmer, Mariana Pavon-Eternod, Thomas E Jones, Sebastien Landry, Tao Pan, Matthew D Weitzman,[...]. Nature 2012
198
24

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
Sai-Wen Tang, Sven Bilke, Liang Cao, Junko Murai, Fabricio G Sousa, Mihoko Yamade, Vinodh Rajapakse, Sudhir Varma, Lee J Helman, Javed Khan,[...]. Clin Cancer Res 2015
58
41

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
C Allison Stewart, Pan Tong, Robert J Cardnell, Triparna Sen, Lerong Li, Carl M Gay, Fatemah Masrorpour, You Fan, Rasha O Bara, Ying Feng,[...]. Oncotarget 2017
91
26

The schlafen family of proteins and their regulation by interferons.
Evangelos Mavrommatis, Eleanor N Fish, Leonidas C Platanias. J Interferon Cytokine Res 2013
81
27

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
19


CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.
Vinodh N Rajapakse, Augustin Luna, Mihoko Yamade, Lisa Loman, Sudhir Varma, Margot Sunshine, Francesco Iorio, Fabricio G Sousa, Fathi Elloumi, Mirit I Aladjem,[...]. iScience 2018
66
25

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
16

Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan.
Li Tian, Santai Song, Xiaojing Liu, Yan Wang, Xiaoguang Xu, Yi Hu, Jianming Xu. Anticancer Drugs 2014
35
42

Evolution of the Schlafen genes, a gene family associated with embryonic lethality, meiotic drive, immune processes and orthopoxvirus virulence.
Olivia Bustos, Saijal Naik, Gayle Ayers, Claudio Casola, Maria A Perez-Lamigueiro, Paul T Chippindale, Ellen J Pritham, Elena de la Casa-Esperón. Gene 2009
64
23

The NCI-60 Methylome and Its Integration into CellMiner.
William C Reinhold, Sudhir Varma, Margot Sunshine, Vinodh Rajapakse, Augustin Luna, Kurt W Kohn, Holly Stevenson, Yonghong Wang, Holger Heyn, Vanesa Nogales,[...]. Cancer Res 2017
29
51

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
14

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Florence Coussy, Rania El-Botty, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Sophie Leboucher, Ludivine Morisset, Pierre Painsec, Laura Sourd, Léa Huguet,[...]. Sci Transl Med 2020
34
41

SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.
Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, Megan Slade, Luisa Fernandez, Judy Hess, Rohan Bareja, Panagiotis J Vlachostergios, Michael Sigouros, Juan Miguel Mosquera,[...]. Mol Cancer Ther 2020
22
63

High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment.
Yanhong Deng, Yue Cai, Yan Huang, Zihuan Yang, Yang Bai, Yanlu Liu, Xiuping Deng, Jianping Wang. BMC Cancer 2015
19
68

Systematic identification of genomic markers of drug sensitivity in cancer cells.
Mathew J Garnett, Elena J Edelman, Sonja J Heidorn, Chris D Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, I Richard Thompson, Xi Luo, Jorge Soares,[...]. Nature 2012
13

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
Eric Polley, Mark Kunkel, David Evans, Thomas Silvers, Rene Delosh, Julie Laudeman, Chad Ogle, Russell Reinhart, Michael Selby, John Connelly,[...]. J Natl Cancer Inst 2016
85
12

Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.
Tao He, Meiying Zhang, Ruipan Zheng, Shufang Zheng, Enqiang Linghu, James G Herman, Mingzhou Guo. Epigenomics 2017
26
42


Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress.
Junko Murai, Hongliang Zhang, Lorinc Pongor, Sai-Wen Tang, Ukhyun Jo, Fumiya Moribe, Yixiao Ma, Masaru Tomita, Yves Pommier. Cell Rep 2020
16
68

Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq.
Tsuyoshi Takashima, Naoya Sakamoto, Junko Murai, Daiki Taniyama, Ririno Honma, Shoichi Ukai, Ryota Maruyama, Kazuya Kuraoka, Vinodh N Rajapakse, Yves Pommier,[...]. Virchows Arch 2021
12
91

Correlating chemical sensitivity and basal gene expression reveals mechanism of action.
Matthew G Rees, Brinton Seashore-Ludlow, Jaime H Cheah, Drew J Adams, Edmund V Price, Shubhroz Gill, Sarah Javaid, Matthew E Coletti, Victor L Jones, Nicole E Bodycombe,[...]. Nat Chem Biol 2016
281
10

Comprehensive genomic profiles of small cell lung cancer.
Julie George, Jing Shan Lim, Se Jin Jang, Yupeng Cun, Luka Ozretić, Gu Kong, Frauke Leenders, Xin Lu, Lynnette Fernández-Cuesta, Graziella Bosco,[...]. Nature 2015
905
10

Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity.
Fabricio G Sousa, Renata Matuo, Sai-Wen Tang, Vinodh N Rajapakse, Augustin Luna, Chris Sander, Sudhir Varma, Paul H G Simon, James H Doroshow, William C Reinhold,[...]. DNA Repair (Amst) 2015
36
27

Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control.
Jin-Yu Yang, Xiang-Yu Deng, Yi-Sheng Li, Xian-Cai Ma, Jian-Xiong Feng, Bing Yu, Yang Chen, Yi-Ling Luo, Xi Wang, Mei-Ling Chen,[...]. Nat Commun 2018
40
25

Targeting Topoisomerase I in the Era of Precision Medicine.
Anish Thomas, Yves Pommier. Clin Cancer Res 2019
60
16

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.
Claudia Winkler, Joshua Armenia, Gemma N Jones, Luis Tobalina, Matthew J Sale, Tudor Petreus, Tarrion Baird, Violeta Serra, Anderson T Wang, Alan Lau,[...]. Br J Cancer 2021
12
83

Subcellular localization of the Schlafen protein family.
Brent Neumann, Liang Zhao, Kathleen Murphy, Thomas J Gonda. Biochem Biophys Res Commun 2008
48
18

Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.
Efstratios Katsoulidis, Evangelos Mavrommatis, Jennifer Woodard, Mario A Shields, Antonella Sassano, Nathalie Carayol, Konrad T Sawicki, Hidayatullah G Munshi, Leonidas C Platanias. J Biol Chem 2010
55
16

Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells.
Alexander Puck, Regina Aigner, Madhura Modak, Petra Cejka, Dieter Blaas, Johannes Stöckl. Results Immunol 2015
35
25

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
Lauren Averett Byers, Jing Wang, Monique B Nilsson, Junya Fujimoto, Pierre Saintigny, John Yordy, Uma Giri, Michael Peyton, You Hong Fan, Lixia Diao,[...]. Cancer Discov 2012
295
9

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer.
Alberto Ballestrero, Davide Bedognetti, Domenico Ferraioli, Paola Franceschelli, Sana Intidhar Labidi-Galy, Elisabetta Leo, Junko Murai, Yves Pommier, Petros Tsantoulis, Valerio Gaetano Vellone,[...]. J Transl Med 2017
17
52

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.
Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
300
9

SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing.
Riccardo Mezzadra, Marjolein de Bruijn, Lucas T Jae, Raquel Gomez-Eerland, Anja Duursma, Ferenc A Scheeren, Thijn R Brummelkamp, Ton N Schumacher. PLoS One 2019
19
47

The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib.
Laetitia Marzi, Ludmila Szabova, Melanie Gordon, Zoe Weaver Ohler, Shyam K Sharan, Michael L Beshiri, Moudjib Etemadi, Junko Murai, Kathleen Kelly, Yves Pommier. Clin Cancer Res 2019
14
64

Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.
Min H Kang, Jing Wang, Monish R Makena, Joo-Sang Lee, Nancy Paz, Connor P Hall, Michael M Song, Ruben I Calderon, Riza E Cruz, Ashly Hindle,[...]. Clin Cancer Res 2015
55
14

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, Johannes Brägelmann, Ismail Can, Paul M Ballieu, Annika Marx, Julie George, Christine Heinen, Milind D Chalishazar,[...]. Cancer Cell 2017
200
8

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
8

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
929
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.